Ascendis Pharma A/SASND

NASDAQHealthcareBiotechnology$225.98-1.32%

Focused on developing long-acting therapies for rare endocrine diseases, this Denmark-based biotechnology company uses its proprietary TransCon drug delivery platform to create sustained-release versions of established biologics. Its lead commercial product, Skytrofa for pediatric growth hormone def...

Market Cap: $13.9B52W Range: $124.06 – $248.60

Congressional Interest in Ascendis Pharma A/S (ASND)

No congressional trades have been disclosed for Ascendis Pharma A/S (ASND) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures

Unique Politicians

Buys

Sells

Who in Congress Is Trading ASND?

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

Ascendis Pharma A/SASND

Congressional Interest in Ascendis Pharma A/S (ASND)

Who in Congress Is Trading ASND?

Related